- Recruiting
Longitudinal Early-onset Alzheimer's Disease Study Protocol
This study looks at how early-onset Alzheimer's disease develops over time. It compares people with this condition to those without it, gathering information on memory, brain scans, and other health markers to better understand the disease.
For: Early Onset Alzheimer Disease · Alzheimer Disease · Mild Cognitive ImpairmentUnited States · Argentina · Netherlands - Ongoing, recruitingTherapeutic exploratory (Phase II)
I5T-MC-AACI: Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
This study, called I5T-MC-AACI, is looking at a new medicine called Donanemab for people in the early stages of Alzheimer's disease. Researchers want to see if it's safe, how well people tolerate it, and if it helps with symptoms. It's a Phase II study, which means it's still in early testing.
For: Alzheimer DiseaseNetherlands · Czechia · Poland - Ongoing, recruitingTherapeutic exploratory (Phase II)
I9X-MC-MTAE: Assessment of Safety, Tolerability, and Efficacy of LY3372689 in Early Symptomatic Alzheimer’s Disease
This study is looking into a new medication for people in the early stages of Alzheimer's disease. Researchers want to see if the medication, called LY3372689, is safe, has side effects, and if it helps improve or slow down symptoms compared to a dummy treatment.
For: Alzheimer DiseasePoland